Factors Examined for End-of-Life Spending Levels in Cancer Care

Share this content:
Factors Examined for End-of-Life Spending Levels in Cancer Care
Factors Examined for End-of-Life Spending Levels in Cancer Care

TUESDAY, Aug. 7, 2018 (HealthDay News) -- Geographic variation in end-of-life spending can be explained by availability of services and physicians' beliefs, but not patients' beliefs, according to a study published in the July issue of Health Affairs.

Nancy L. Keating, M.D., M.P.H., from Harvard Medical School in Boston, and colleagues examined the extent to which variation in health care spending in the months before death is explained by differences in patients' sociodemographic factors, clinical factors, and beliefs; physicians' beliefs; and service availability. Data were included for 1,132 patients aged 65 years and older diagnosed with lung or colorectal cancer in 2003 to 2005, had advanced stage cancer, died before 2013, and were enrolled in fee-for-service Medicare.

The researchers found that the mean expenditures were $13,663 for the last month of life. Compared with those in lower-spending areas, physicians in higher-spending areas reported less knowledge about and comfort with treating dying patients and less positive attitudes about hospice. Compared with lower-spending areas, higher-spending areas had more physicians and fewer primary care providers and hospices in proportion to their total population. Physicians in higher-spending areas also reported less knowledge about and comfort with treating dying patients and less positive attitudes about hospice compared to those in lower-spending areas.

"Availability of services and physicians' beliefs, but not patients' beliefs, were important in explaining geographic variations in end-of-life spending," the authors write. "Enhanced training to better equip physicians to care for patients at the end of life and strategic resource allocation may have potential for decreasing unwarranted variation in care."

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves First Customizable Insulin Pump

FDA Approves First Customizable Insulin Pump

Product works by delivering insulin under the skin at set or variable rates

Sepsis Common in Terminal Hospitalizations, Discharges

Sepsis Common in Terminal Hospitalizations, Discharges

Most common underlying causes of death in sepsis are solid and hematologic cancers, chronic heart disease

Fewer Older Men Assessed, Treated for Osteoporosis

Fewer Older Men Assessed, Treated for Osteoporosis

Fewer older men than women, even with higher risk, undergo DXA screening, 25(OH)D measurement

is free, fast, and customized just for you!




Already a member?

Sign In Now »